Targeting compound for treating cat fatty liver and preparation method thereof

• Main Authors: GAO WEI, LIU WAN, ZHANG YANSHENG, BAO WEIYANG, WANG ZUZHE
• Format: Patent
• Language: Chinese; English
• Published: 22.12.2023
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention relates to a targeting compound for treating cat fatty liver and a preparation method thereof, belongs to the technical field of biology, is used for solving the problem of treating cat fatty liver, and is characterized in that the compound comprises astaxanthin and a composite carrier, and the composite carrier comprises sea cucumber oligopeptide, fish maw oligopeptide and a galactosylated bacterial cellulose carrier; the mass ratio of the astaxanthin to the composite carrier is 1: (10-100), the mass ratio of the sea cucumber oligopeptide to the fish maw oligopeptide to the galactosylated bacterial cellulose carrier in the composite carrier is (1-3): (1-3): 1, the cat fatty liver can be improved and treated, and the liver targeting property is achieved. 治疗猫脂肪肝的靶向复合物及其制备方法，属于生物技术领域，用于解决猫脂肪肝治疗的问题，要点是复合物包括虾青素以及复合载体，其中，复合载体包括海参低聚肽、花胶低聚肽以及半乳糖基化细菌纤维素载体；虾青素与复合载体的质量比为1:(10～100)，复合载体中的海参低聚肽、花胶低聚肽以及半乳糖基化细菌纤维素载体的质量比为(1～3):(1～3):1，效果是能够改善和治疗猫脂肪肝，且具有肝靶向性。